Genomics in Cancer Care Market: Competitive Landscape, Pharma–Diagnostics Alliances, and Growing Role of Real-World Genomic Data in Drug Development
The Genomics in Cancer Care Market is intensifying competitively as sequencing companies, diagnostic labs, and pharmaceutical firms form alliances and leverage real-world genomic data to drive oncology drug development. With the global market expected to climb from roughly USD 46–54 billion in 2024–2025 to around USD 219–220 billion by 2035, strategic collaborations are...
0 Comments 0 Shares 119 Views 0 Reviews